Clinical value of prostate-specific antigen combined with tumor abnormal protein (TAP) in the diagnosis of prostate puncture

BACKGROUND: In this study, we aimed to test the clinical value of total prostate-specific antigen (T-PSA), free prostate-specific antigen (F-PSA), and T-PSA combined with tumor abnormal glycoprotein (TAP) for early diagnosis of prostate cancer. METHODS: The levels of serum T-PSA and F-PSA were measu...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Yu, Yin, Shuiping, Liang, Chaozhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799093/
https://www.ncbi.nlm.nih.gov/pubmed/35117158
http://dx.doi.org/10.21037/tcr.2019.11.05

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799093/
https://www.ncbi.nlm.nih.gov/pubmed/35117158
http://dx.doi.org/10.21037/tcr.2019.11.05

Ejemplares similares